AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24660827 — intervention group
Group type: EXPERIMENTAL
Intervention: BAK-preserved artificial tears
Number of subjects: 44
Study 24660827 — intervention group
Group type: COMPARATOR
Intervention: Preservative-free artificial tears
Number of subjects: 44
Study 22726593 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD8848 (30-100 μg)
Number of subjects: 86
Study 22726593 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD8848 (30 and 60 μg)
Number of subjects: 86
Study 22726593 — intervention group
Group type: COMPARATOR
Intervention: AZD8848 (0.3-600 μg)
Number of subjects: 86
Study 22726593 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD8848
Number of subjects: 86
Study 20147603 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg
Number of subjects: 90
Study 20147603 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg
Number of subjects: 90
Study 20147603 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin/Ezetimibe 5 mg/5 mg
Number of subjects: 90
Study 20147603 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin 20 mg, Rosuvastatin 10 mg, Atorvastatin/Ezetimibe 5 mg/5 mg
Number of subjects: 90
Study 18305126 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil 40 mg once daily for 10 days
Number of subjects: 15
Study 18305126 — intervention group
Group type: EXPERIMENTAL
Intervention: Bosentan 125 mg twice daily for 10 days
Number of subjects: 15
Study 18305126 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of tadalafil and bosentan for 10 days
Number of subjects: 15
Study 14738561 — intervention group
Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil (ADV) therapy
Number of subjects: 22
Study 11480308 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered questionnaire (SAQ)
Number of subjects: 601
Study 11480308 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face (FTF) interview
Number of subjects: 601
Study 9333281 — intervention group
Group type: EXPERIMENTAL
Intervention: Nylon sutures
Number of subjects: 50
Study 9333281 — intervention group
Group type: COMPARATOR
Intervention: Surgical staplers
Number of subjects: 50
Study 8432223 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose 25 mg powdered, 3 times a day with meals for 3 months
Number of subjects: 6
Study 8432223 — intervention group
Group type: COMPARATOR
Intervention: Placebo, 3 times a day with meals for 3 months
Number of subjects: 6
Study 8432223 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose 25 mg powdered, 3 times a day with meals
Number of subjects: 6
Study 3829440 — intervention group
Group type: EXPERIMENTAL
Intervention: S-carboxymethylcysteine (2.25 g per day for 7 days)
Number of subjects: 0
Study 3829440 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31791364 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 319
Study 31791364 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition
Number of subjects: 319
Study 31791364 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise plus Nutrition (Combination)
Number of subjects: 319
Study 31791364 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 319
Study 31791364 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise, Nutrition, and Combination groups
Number of subjects: 319
Study 31791364 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition group
Number of subjects: 319
Study 30320657 — intervention group
Group type: EXPERIMENTAL
Intervention: Lavender oil inhalation (2 drops placed 15 to 20 cm away from the pillow, 30 minutes before bed for 1 week)
Number of subjects: 34
Study 30320657 — intervention group
Group type: EXPERIMENTAL
Intervention: Lavender oil inhalation
Number of subjects: 34
Study 30320657 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 34
Study 26606329 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care hormone therapy (HT) alone
Number of subjects: 721
Study 26606329 — intervention group
Group type: EXPERIMENTAL
Intervention: Planned use of radiotherapy (RT)
Number of subjects: 721
Study 24360138 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care
Number of subjects: 259
Study 24360138 — intervention group
Group type: COMPARATOR
Intervention: Antidepressant medication
Number of subjects: 259
Study 22364552 — intervention group
Group type: EXPERIMENTAL
Intervention: Better air quality (median CO₂ level 1045 ppm)
Number of subjects: 417
Study 22364552 — intervention group
Group type: COMPARATOR
Intervention: Worse air quality (median CO₂ level 2115 ppm)
Number of subjects: 417
Study 19514069 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidimensional Fatigue Inventory (MFI)
Number of subjects: 153
Study 19514069 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidimensional Fatigue Inventory (MFI) after controlling for depression
Number of subjects: 153
Study 17215186 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vitamin B12 supplementation (500 microg)
Number of subjects: 42
Study 17215186 — intervention group
Group type: COMPARATOR
Intervention: Control group (no vitamin B12 supplementation)
Number of subjects: 42
Study 17215186 — intervention group
Group type: COMPARATOR
Intervention: Green leafy vegetables (100 g every alternate day)
Number of subjects: 42
Study 17215186 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose per oral vitamin B12 supplementation
Number of subjects: 42
Study 17215186 — intervention group
Group type: COMPARATOR
Intervention: Vibration sensory threshold
Number of subjects: 42
Study 15094145 — intervention group
Group type: EXPERIMENTAL
Intervention: Force sense (contralateral force sense reproduction)
Number of subjects: 40
Study 15094145 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint reposition sense
Number of subjects: 40
Study 11014400 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment Group 1 (acupuncture distal to tourniquet)
Number of subjects: 60
Study 11014400 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment Group 2 (acupuncture proximal to tourniquet)
Number of subjects: 60
Study 11014400 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo Group 1 (sham acupuncture on nonacupuncture points)
Number of subjects: 60
Study 11014400 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo Group 2 (sham acupuncture on acupuncture points)
Number of subjects: 60
Study 11014400 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 60
Study 9306087 — intervention group
Group type: EXPERIMENTAL
Intervention: beta-glucan-rich oat bran
Number of subjects: 36
Study 9306087 — intervention group
Group type: COMPARATOR
Intervention: wheat bran
Number of subjects: 36
Study 8317404 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ketorolac tromethamine (KT)
Number of subjects: 60
Study 8317404 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 3728375 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed beam (neutron/photon) radiotherapy
Number of subjects: 102
Study 3728375 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast neutron radiotherapy
Number of subjects: 102
Study 3728375 — intervention group
Group type: COMPARATOR
Intervention: Conventional radiotherapy (photon)
Number of subjects: 102
Study 3728375 — intervention group
Group type: EXPERIMENTAL
Intervention: All arms (mixed beam, neutrons, photons)
Number of subjects: 102
Study 3728375 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutron and mixed beam arms
Number of subjects: 102
Study 30033064 — intervention group
Group type: COMPARATOR
Intervention: High-dose dexamethasone (20 mg) and 2 injections of normal saline (group B)
Number of subjects: 182
Study 30033064 — intervention group
Group type: COMPARATOR
Intervention: High-dose dexamethasone (20 mg) and 2 injections of low-dose (10 mg) dexamethasone (group C)
Number of subjects: 182
Study 30033064 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (group A)
Number of subjects: 182
Study 27028537 — intervention group
Group type: EXPERIMENTAL
Intervention: Squatting position using bars
Number of subjects: 102
Study 27028537 — intervention group
Group type: COMPARATOR
Intervention: Supine position modified to 45 degree of semi-fowler
Number of subjects: 102
Study 25633755 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E infused highly cross-linked polyethylene (E-poly™) with 32 mm heads
Number of subjects: 50
Study 25633755 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E infused highly cross-linked polyethylene (E-poly™) with 36 mm heads
Number of subjects: 50
Study 25633755 — intervention group
Group type: COMPARATOR
Intervention: Comparison of 32 mm and 36 mm heads
Number of subjects: 50
Study 23228033 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with clinical‐radiological severity mismatch (NIHSS score ≥ 10 and infarct volume <20 cc)
Number of subjects: 277
Study 23228033 — intervention group
Group type: COMPARATOR
Intervention: Patients with NIHSS score ≥ 10 and infarct volume ≥ 20 cc
Number of subjects: 277
Study 21942462 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobramycin solution for inhalation (TSI) users
Number of subjects: 832
Study 21942462 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobramycin solution for inhalation (TSI) users (low adherence)
Number of subjects: 832
Study 21942462 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobramycin solution for inhalation (TSI) users (medium adherence)
Number of subjects: 832
Study 21942462 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobramycin solution for inhalation (TSI) users (high adherence)
Number of subjects: 832
Study 21942462 — intervention group
Group type: COMPARATOR
Intervention: Non-users of TSI
Number of subjects: 832
Study 18292412 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine management supplemented by an active underbody forced-air system (n = 30)
Number of subjects: 60
Study 18292412 — intervention group
Group type: COMPARATOR
Intervention: Routine thermal management (fluid warming and passive insulation, n = 30)
Number of subjects: 60
Study 16449523 — intervention group
Group type: EXPERIMENTAL
Intervention: R-CHOP
Number of subjects: 199
Study 16449523 — intervention group
Group type: COMPARATOR
Intervention: CHOP
Number of subjects: 199
Study 14626184 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongnao Huoluo acupuncture (TNHLA) therapy
Number of subjects: 0
Study 14626184 — intervention group
Group type: COMPARATOR
Intervention: Immediate thrombolysis by intravenously given urokinase 12 million units
Number of subjects: 0
Study 14626184 — intervention group
Group type: COMPARATOR
Intervention: Simple body acupuncture
Number of subjects: 0
Study 14626184 — intervention group
Group type: COMPARATOR
Intervention: Intravenous dripping of normal saline (placebo)
Number of subjects: 0
Study 14626184 — intervention group
Group type: EXPERIMENTAL
Intervention: TNHLA
Number of subjects: 0
Study 14626184 — intervention group
Group type: COMPARATOR
Intervention: Thrombolysis
Number of subjects: 0
Study 10607320 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% isotretinoin
Number of subjects: 800
Study 10607320 — intervention group
Group type: COMPARATOR
Intervention: Vehicle cream
Number of subjects: 800
Study 9106870 — intervention group
Group type: EXPERIMENTAL
Intervention: Child dentifrice (CD)
Number of subjects: 50
Study 9106870 — intervention group
Group type: COMPARATOR
Intervention: Adult dentifrice (AD)
Number of subjects: 50
Study 8427721 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 0
Study 8427721 — intervention group
Group type: COMPARATOR
Intervention: Norfloxacin
Number of subjects: 0
Study 8427721 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoroquinolones (general)
Number of subjects: 0
Study 30449719 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab 7.5 mg/kg every 3 weeks for 6 cycles followed by single-agent bevacizumab for 12 further cycles (total duration 12 months)
Number of subjects: 1160
Study 30449719 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin and paclitaxel alone
Number of subjects: 1160
Study 30449719 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin and paclitaxel with bevacizumab
Number of subjects: 1160
Study 27813617 — intervention group
Group type: EXPERIMENTAL
Intervention: 99mTc‐MIBI scintigraphy (washout technique)
Number of subjects: 40
Study 27639625 — intervention group
Group type: EXPERIMENTAL
Intervention: High-pitch computed tomography (HPCT) under free breathing (FB)
Number of subjects: 100
Study 27639625 — intervention group
Group type: COMPARATOR
Intervention: Standard-pitch CT (SPCT) under breath-hold (BH)
Number of subjects: 100
Study 25164872 — intervention group
Group type: EXPERIMENTAL
Intervention: Exogenous surfactant (200 mg/kg poractant alfa) via the Hobart method
Number of subjects: 606
Study 25164872 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 606
Study 21870101 — intervention group
Group type: EXPERIMENTAL
Intervention: Alumina heads
Number of subjects: 0
Study 21870101 — intervention group
Group type: COMPARATOR
Intervention: Cobalt-chrome heads
Number of subjects: 0
Study 20647334 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based helmet promotion program (1-month intervention based on the Health Belief Model)
Number of subjects: 741
Study 20647334 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 741
Study 18922386 — intervention group
Group type: EXPERIMENTAL
Intervention: Camu-camu juice (70 ml daily for 7 days, 1050 mg of vitamin C)
Number of subjects: 20
Study 18922386 — intervention group
Group type: COMPARATOR
Intervention: Vitamin C tablets (1050 mg for 7 days)
Number of subjects: 20
Study 16019622 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary hempseed oil
Number of subjects: 0
Study 16019622 — intervention group
Group type: COMPARATOR
Intervention: Olive oil
Number of subjects: 0
Study 12504260 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-generation Moroccan migrant patients
Number of subjects: 272
Study 12504260 — intervention group
Group type: COMPARATOR
Intervention: Belgian patients
Number of subjects: 272
Study 10363425 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of TNF-alpha activity in peritoneal fluid (PF)
Number of subjects: 73
Study 10363425 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolation of bacteria from peritoneal fluid
Number of subjects: 73
Study 10363425 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of TNF-alpha with bacterial isolation
Number of subjects: 73
Study 7794222 — intervention group
Group type: EXPERIMENTAL
Intervention: Tyrosine (150 mg.kg‐1 in a split dose)
Number of subjects: 2
Study 7794222 — intervention group
Group type: COMPARATOR
Intervention: Cornstarch placebo
Number of subjects: 2
Study 1951222 — intervention group
Group type: EXPERIMENTAL
Intervention: Acellular pertussis vaccines
Number of subjects: 0
Study 1951222 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 6972026 — intervention group
Group type: EXPERIMENTAL
Intervention: Domperidone 10 mg
Number of subjects: 0
Study 6972026 — intervention group
Group type: EXPERIMENTAL
Intervention: Domperidone 20 mg
Number of subjects: 0
Study 6972026 — intervention group
Group type: EXPERIMENTAL
Intervention: Domperidone 40 mg
Number of subjects: 0
Study 6972026 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo not specified)
Number of subjects: 0
Study 29779422 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Portal Use (PPs)
Number of subjects: 272
Study 29779422 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative feedback from participants
Number of subjects: 272
Study 30527787 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual registration biopsy
Number of subjects: 129
Study 30527787 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI/ultrasound image-fusion biopsy (SmartTarget)
Number of subjects: 129
Study 30527787 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined strategies (visual registration and image-fusion)
Number of subjects: 129
Study 30527787 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events related to biopsy
Number of subjects: 129
Study 30527787 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary symptoms, erectile function, quality of life
Number of subjects: 129
Study 28663267 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadoterate meglumine (0.1 mmol/kg)
Number of subjects: 279
Study 28663267 — intervention group
Group type: COMPARATOR
Intervention: Gadobutrol (0.1 mmol/kg)
Number of subjects: 279
Study 25858239 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment following intravenous tissue-type plasminogen activator
Number of subjects: 656
Study 25858239 — intervention group
Group type: COMPARATOR
Intervention: Intravenous tissue-type plasminogen activator alone
Number of subjects: 656
Study 23352440 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-week group physical training, dietary education and physiotherapy intervention
Number of subjects: 251
Study 23352440 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-week group intervention
Number of subjects: 251
Study 21159430 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal transcutaneous spinal cord direct current stimulation (tsDCS) at 2mA for 15 minutes
Number of subjects: 11
Study 21159430 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tsDCS
Number of subjects: 11
Study 21159430 — intervention group
Group type: COMPARATOR
Intervention: Sham tsDCS
Number of subjects: 11
Study 21159430 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tsDCS
Number of subjects: 11
Study 19590458 — intervention group
Group type: EXPERIMENTAL
Intervention: CEE/MPA (0.625 mg conjugated equine estrogens plus 2.5 mg medroxyprogesterone acetate)
Number of subjects: 66
Study 19590458 — intervention group
Group type: COMPARATOR
Intervention: Red clover (120 mg)
Number of subjects: 66
Study 19590458 — intervention group
Group type: COMPARATOR
Intervention: Black cohosh (128 mg)
Number of subjects: 66
Study 19590458 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 17919253 — intervention group
Group type: EXPERIMENTAL
Intervention: AdheSE
Number of subjects: 50
Study 17919253 — intervention group
Group type: COMPARATOR
Intervention: Excite
Number of subjects: 50
Study 17919253 — intervention group
Group type: EXPERIMENTAL
Intervention: Both adhesive systems
Number of subjects: 50
Study 15497663 — intervention group
Group type: COMPARATOR
Intervention: Azithromycin 500 mg tablets
Number of subjects: 24
Study 15497663 — intervention group
Group type: COMPARATOR
Intervention: Azithromycin 200 mg/5 mL suspension
Number of subjects: 24
Study 15497663 — intervention group
Group type: COMPARATOR
Intervention: Azithromycin (both formulations)
Number of subjects: 24
Study 11547053 — intervention group
Group type: EXPERIMENTAL
Intervention: Shock wave lithotripsy
Number of subjects: 64
Study 11547053 — intervention group
Group type: COMPARATOR
Intervention: Ureteroscopy
Number of subjects: 64
Study 9331518 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram 20 mg once daily for 10 days
Number of subjects: 18
Study 9331518 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram 20 mg once daily for 10 days + Selegiline 10 mg once daily for 4 days
Number of subjects: 18
Study 9331518 — intervention group
Group type: EXPERIMENTAL
Intervention: Selegiline 10 mg once daily for 4 days after citalopram washout
Number of subjects: 18
Study 9331518 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 7932291 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-day time-management training program
Number of subjects: 56
Study 7932291 — intervention group
Group type: COMPARATOR
Intervention: Control group (did not attend training)
Number of subjects: 56
Study 2831262 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (NS) 1% solution, 0.13 ml nasal spray, administered at least twice daily
Number of subjects: 36
Study 31689138 — intervention group
Group type: EXPERIMENTAL
Intervention: New class I Medical Device (MD)
Number of subjects: 90
Study 31689138 — intervention group
Group type: COMPARATOR
Intervention: Sunscreen alone (SPF 100+)
Number of subjects: 90
Study 31768718 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary intervention for encopresis (MIE); Treatment for constipation, 10-day behavioral intervention utilizing suppositories
Number of subjects: 20
Study 31768718 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 20
Study 27003676 — intervention group
Group type: EXPERIMENTAL
Intervention: Reread‐Adapt and Answer‐Comprehend (RAAC) + Goal Setting intervention
Number of subjects: 5
Study 26833928 — intervention group
Group type: EXPERIMENTAL
Intervention: Learn to forgive group programme
Number of subjects: 36
Study 26833928 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (90-minute video on forgiveness)
Number of subjects: 36
Study 26311155 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 69
Study 26311155 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 69
Study 24034150 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound (EUS)
Number of subjects: 223
Study 24034150 — intervention group
Group type: COMPARATOR
Intervention: Standard staging algorithm
Number of subjects: 223
Study 21950699 — intervention group
Group type: EXPERIMENTAL
Intervention: Blue light-filtering IOL (acrysof IQ (SN60WF) [Alcon])
Number of subjects: 50
Study 21950699 — intervention group
Group type: COMPARATOR
Intervention: Clear IOL (Tecnis (Z9003) [AMO])
Number of subjects: 50
Study 21950699 — intervention group
Group type: EXPERIMENTAL
Intervention: Both IOL groups
Number of subjects: 50
Study 19006027 — intervention group
Group type: EXPERIMENTAL
Intervention: PTRA + ILBT
Number of subjects: 71
Study 19006027 — intervention group
Group type: COMPARATOR
Intervention: PTRA
Number of subjects: 71
Study 17032439 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-menu questions (LMQs)
Number of subjects: 146
Study 17032439 — intervention group
Group type: COMPARATOR
Intervention: Open-ended questions (OEQs)
Number of subjects: 146
Study 12848218 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis
Number of subjects: 0
Study 12848218 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 10371003 — intervention group
Group type: COMPARATOR
Intervention: Interocclusal appliance therapy
Number of subjects: 26
Study 10371003 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic jaw exercises
Number of subjects: 26